Page last updated: 2024-10-26

valproic acid and Leukemia, Erythroblastic, Acute

valproic acid has been researched along with Leukemia, Erythroblastic, Acute in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koyama, N1
Koschmieder, S1
Tyagi, S1
Nürnberger, H1
Wagner, S1
Böcker, U1
Hoelzer, D1
Gerhard Ottmann, O1
Kalina, U1

Other Studies

1 other study available for valproic acid and Leukemia, Erythroblastic, Acute

ArticleYear
Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells.
    Biochemical and biophysical research communications, 2002, Apr-12, Volume: 292, Issue:4

    Topics: Blotting, Northern; Blotting, Western; Butyrates; Cell Differentiation; Cell Division; Cell Line; Ce

2002